Protective Effect of Insulin Sensitizer Rosiglitazone on SH-SY5Y Cell Against Streptozotocin-induced Injury

张景燕,王蓉,盛树力,姬志娟,孟祥宏,赵志炜
DOI: https://doi.org/10.3969/j.issn.1006-7795.2010.01.015
2010-01-01
Abstract:Objective To investigate the effect of insulin sensitizer rosiglitazone on streptozotocin(STZ)-induced insulin signal transduction pathway injury in SH-SY5Y cells.Methods Cells from human neuroblastoma cell line SH-SY5Y were divided into control group,STZ 0.8 mmol/L group,STZ 0.8 mmol/L+rosiglitazone 20 μmol/L group.The cells were counted,MTT(MTT) metabolic rate,lactate dehydrogenase(LDH) leakage rate in each group were measured,and the effect of rosiglitazone on SH-SY5Y cells was observed.Results Compared with the control group,cell count and MTT metabolic rate of STZ model decreased(P0.01),and LDH leakage rate increased(P0.01).After rosiglitazone protection,these indicators were significantly improved,cell count and MTT metabolic rate were higher than that in STZ injury group(P0.01),LDH leakage rate was lower(P0.01).Conclusion Rosiglitazone can reduce STZ-induced nerve cell toxicity,to improve cell survival,though its mechanism still need to be further explored.
What problem does this paper attempt to address?